GENMET-VEC
Live / Registered — Registered (as of 18 Apr 2023)
What this means for you
Registered since 18 Apr 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97017702
- Registration number
- 7032316
- Mark type
- Stylized text
- Filed
- 08 Sept 2021
- Published for opposition
- 19 Jul 2022
- Registered
- 18 Apr 2023
- Attorney of record
- Yue (Robert) Xu
Goods and services
- Class 005 — Pharmaceuticals: Anti-cancer preparations; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Human vaccine preparations; Antibiotics for human use; Dietary supplements for human consumption; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Radioactive substances for medical purposes; Gases for medical and dental use; Gases and gas mixtures for medical imaging use; Cartridges sold pre-filled with gases and gas mixtures for medical use; Disinfectants; Bacteriological culture mediums; Dietetic foods adapted for medical purposes; Surgical dressings; All containing in whole or significant part, gene therapy substances
Owner
- Guangzhou Sinogen Pharmaceutical Co., Ltd., Guangdong Province, CN
- Guangzhou Sinogen Pharmaceutical Co., Ltd., Guangdong Province, CN
- Guangzhou Sinogen Pharmaceutical Co., Ltd., Guangdong Province, CN
Prior registrations
Prosecution history
- 18 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
- 14 Mar 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Mar 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Mar 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Feb 2023 — USE AMENDMENT FILED
- 10 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Feb 2023 — TEAS STATEMENT OF USE RECEIVED
- 13 Sept 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Jul 2022 — PUBLISHED FOR OPPOSITION
- 29 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Jun 2022 — ASSIGNED TO EXAMINER
- 18 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED